Programme: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Main Arena 1

48 events

Monday, January 25th: 7:30 - 9:00, Main Arena 1

Advanced concepts for complex aortoiliac obstructions

Moderator:

Peter Goverde, Ramon Varcoe

Panel:

Hans Krankenberg, Michel Reijnen, Patrice Mwipatayi
1. 07:30 - 07:55
  
  Live case transmission from Leipzig
2. 07:55 - 08:00
  
  The CERAB technique – procedural tips and clinical outcome
3. 08:00 - 08:05
  
  Clinical experience between kissing stents and CERAB
4. 08:05 - 08:10
  
  Outcomes of self expanding PTFE covered stent vs. bare metal stent for chronic iliac artery occlusion
5. 08:10 - 08:15
  
  FLEX study: 3 year follow-up of patients with iliac occlusive disease treated with the Viabahn balloon-expandable endoprosthesis
6. 08:15 - 08:40
  
  Live case transmission from Münster
7. 08:40 - 08:45
  
  Ambulatory treatment and the advantages of trans-radial access
8. 08:45 - 08:50
  
  Covered stents in emergencies – why should we all have enough covered stents on the shelf?
9. 08:50 - 08:55
  
  My algorithm for aortoiliac occlusive disease treatment: from easy lesions to juxtarenal total aortoiliac occlusions: which technique for which lesion
10. 08:55 - 09:00
  
  Q&A, discussion, and conclusion
Monday, January 25th: 9:15 - 10:00, Main Arena 1

SYMPOSIUM: Stepping towards optimized lower limb treatment – meet the experts

supported by Abbott Vascular

Moderator:

Koen Deloose

Panel:

Jonathan Sobocinski, Francesco Liistro, Luis Palena
1. 09:15 - 09:30
  
  Recorded case presentation: Supera-implantation for a severely calcified popliteal artery-CTO
2. Panel discussion: step by step approach on treating patients with complex SFA
3. 09:40 - 09:50
  
  Live case transmission from Leipzig: BTK-Intervention
4. Panel discussion: tips and tricks for sustainable BTK results
5. Panel discussion: how you close your procedures in the context of Covid?
Monday, January 25th: 10:10 - 11:20, Main Arena 1

Late breaking trial session: pioneering approaches and new data for BTK interventions

Moderator:

Marianne Brodmann, Michael Lichtenberg

Panel:

Francesco Liistro, Wei Guo
1. 10:10 - 10:15
  
  IN.PACT BTK randomized study: 9 month primary outcomes
2. 10:15 - 10:20
  
  Chinese experience of DCB in BTK: 12 month results of the AcoArt II study
3. 10:20 - 10:25
  
  Latest data of DCB in BTK: 12 month results of the AcoArt BTK Italy study
4. 10:25 - 10:30
  
  Luminor in BTK: MERLION trial 12 month outcomes presented for the first time
5. 10:30 - 10:35
  
  Temsirolimus adventitial delivery to improve ANGiographic Outcomes below the knee (TANGO)
6. 10:35 - 10:40
  
  PRESTIGE-study: 12 month results with the SELUTION sirolimus coated balloon in TASC C and D tibial occlusive disease
7. 10:40 - 10:45
  
  A pilot study examining the performance and safety of the temporary spur stent system in infrapopliteal arteries: first-time use with a Limus-coated balloon (DEEPER LIMUS)
8. 10:45 - 10:50
  
  DEEPER OUS trial: a multicenter, single arm trial of the novel temporary spur stent system used in conjunction with a commercially available, paclitaxel-coated balloon
9. 10:50 - 10:55
  
  12 month data from the LimFlow PROMISE I US early feasibility study
10. 10:55 - 11:20
  
  Live case transmission from Leipzig
Monday, January 25th: 11:30 - 12:25, Main Arena 1

SYMPOSIUM: A new era for vascular access: evidence-based strategies for optimizing AV fistula creation and maintenance

supported by Medtronic

Moderator:

Andrew Holden

Panel:

Alexandros Mallios, Jeffrey Hull, Tobias Steinke
1. 11:30 - 11:35
  
  Introduction
2. 11:35 - 11:40
  
  Panel discussion
3. 11:40 - 11:50
  
  Endovascular or surgical AV access creation: which option for which patient?
4. 11:50 - 11:55
  
  Panel discussion
5. 11:55 - 12:05
  
  Challenges in AV access maintenance: treating the cephalic arch
6. 12:05 - 12:10
  
  Panel discussion
7. 12:10 - 12:20
  
  My AV access maintenance algorithm
8. 12:20 - 12:25
  
  Panel discussion and programme conclusions
Monday, January 25th: 12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: Is there any DCB covering your needs? Updated efficacy and safety evidence

supported by iVascular

Moderator:

Koen Deloose

Panel:

Tjun Tang, Ralf Langhoff
1. 12:30 - 12:31
  
  Introduction
2. 12:31 - 12:49
  
  Live case transmission from Sonneberg
3. 12:49 - 12:57
  
  First Luminor safety and efficacy outcomes at 3.5 years
4. 12:57 - 13:05
  
  Long and complex lesion management, new 2 years data. 1+1=3
5. 13:05 - 13:13
  
  BTK experience, Luminor outcomes at 1 year
6. 13:13 - 13:15
  
  Q&A, discussion, and closure
Monday, January 25th: 13:15 - 14:10, Main Arena 1

LATE BREAKING TRIAL SESSION: New data and innovative concepts for treatment of femoral arteries – part I

Moderator:

Thomas Zeller, Sabine Steiner

Panel:

Kenneth Rosenfield, Marianne Brodmann
1. FOCUS ON DRUG-ELUTING TECHNOLOGIES
2. 13:15 - 13:20
  
  IN.PACT global full clinical cohort: 5 year outcomes
3. 13:20 - 13:25
  
  The real-world CONSEQUENT ALL COMERS study
4. 13:25 - 13:30
  
  Final long-term mortality results of paclitaxel-coated DCBs from the ILLUMENATE RCTs
5. 13:30 - 13:35
  
  5 year outcomes from the IN.PACT global Asian cohort
6. 13:35 - 13:40
  
  3 year outcomes of the novel KANSHAS drug-coated balloon in treatment of femoropopliteal occlusive disease: the first-in-human KANSHAS 1 study results
7. 13:40 - 13:45
  
  New safety and effectiveness data of Luminor DCB: EffPac trial 3.5 years
8. 13:45 - 13:50
  
  Results of the TRANSCEND study – the randomized and controlled noninferiority trial to evaluate safety and clinical efficacy of the SurVeil™ drug-coated balloon compared to IN.PACT® Admiral® drug-coated balloon in the treatment of femoropopliteal artery disease
9. 13:50 - 13:55
  
  2 year results from the COMPARE-trial comparing low-dose (Ranger) vs. high-dose (Impact) DCB in femoropopliteal arteries
10. 13:55 - 14:00
  
  First peripheral drug-eluting stent clinical results from China: 1 year outcomes of the Zilver PTX China study
11. 14:00 - 14:05
  
  MIMICS-3D: 2 year data from the BioMimics 3D Real world registry
12. 14:05 - 14:10
  
  The vacuum-assisted thromboaspiration in patients with acute lower limb ischaemia: safety and efficacy results from the INDIAN registry
Monday, January 25th: 14:20 - 15:05, Main Arena 1

LATE BREAKING TRIAL SESSION: New data and innovative concepts for treatment of femoral arteries – part II

Moderator:

Thomas Zeller, Sabine Steiner

Panel:

Brian DeRubertis, Ehrin Armstrong, Koen Deloose
1. FOCUS ON NEW DATA FOR COMPLEX LESIONS
2. 14:20 - 14:25
  
  IN.PACT global 4 year DCB alone vs. DCB + provisional stenting outcomes
3. 14:25 - 14:30
  
  24 month outcomes of the combination of Luminor and iVolution in 24 cm lesions: TINTIN trial
4. 14:30 - 14:35
  
  12 month outcomes from the Japanese post-market surveillance study of the Viabahn endoprosthesis as treatment for symptomatic peripheral arterial disease in the superficial femoral arteries
5. 14:35 - 14:40
  
  Outcomes in CLI patients treated with DCB: 4 year results from the IN.PACT global study
6. 14:40 - 14:45
  
  REALITY study 12 month outcomes: safety and effectiveness of directional atherectomy followed by DCB
7. 14:45 - 14:50
  
  Laser atherectomy combined with drug-coated balloon angioplasty is associated with improved 1 year outcomes for the treatment of Tosaka II and III femoropopliteal in-stent restenosis
8. 14:50 - 14:55
  
  In-tack restenosis vs. in-stent restenosis
9. 14:55 - 15:00
  
  TORUS2 late breaking clinical trial data: preliminary 12 month results from interim analysis of the TORUS stent graft
10. 15:00 - 15:05
  
  Fully percutaneous femoropopliteal bypass of complex PAD: population analysis and 24 month results from the DETOUR1 clinical trial
Monday, January 25th: 15:15 - 16:30, Main Arena 1

SYMPOSIUM: Image guided therapy for lower limb revascularization: state of the art

supported by Philips

Moderator:

Theodosios Bisdas

Panel:

Daniel van den Heuvel, Osamu Iida, Nicolas Shammas
1. 15:15 - 15:20
  
  Introduction
2. 15:20 - 15:28
  
  Utilizing complementary imaging modalities to guide strategy and optimize outcomes
3. 15:28 - 15:36
  
  The ABCs of intravascular imaging in contemporary lower limb revascularization
4. 15:36 - 15:56
  
  Live case transmission from Arnsberg
5. 15:56 - 16:04
  
  An optimized angioplasty paradigm: image guided dissection detection and management with a first of its kind dissection repair device
6. 16:04 - 16:24
  
  Recorded case presentation: See clearly treat optimally masterclass
7. 16:24 - 16:30
  
  Discussion and conclusion
Monday, January 25th: 16:45 - 17:45, Main Arena 1

SYMPOSIUM: A spotlight on venous intervention. An insight into when and how

supported by Boston Scientific

Moderator:

Michael Jaff

Panel:

Gerard O'Sullivan, Michael Lichtenberg, Carsten Arnoldussen
1. Live case transmission from Modena
2. FLASH PRESENTATION: Vici venous stent – clinical outcomes and patency at 3 years. Results from the Arnsberg venous registry
3. Live case transmission from Modena
4. Q&A, discussion, and closure
Monday, January 25th: 18:00 - 19:00, Main Arena 1

SYMPOSIUM: Strategies for treating long-segment aortoiliac artery occlusions

supported by Gore & Associates

Moderator:

Gianmarco de Donato

Panel:

Michele Antonello, Tomislav Stojanovic, Jorge Fernández Noya
1. 18:00 - 18:05
  
  Introduction
2. 18:05 - 18:20
  
  Aortoiliac occlusive complex disease: how to treat TASC CD
3. 18:20 - 18:35
  
  Challenging iliac occlusive cases treated with covered stents
4. 18:35 - 18:50
  
  Recorded case: iliac occlusive disease treated with GORE® VIABAHN® VBX balloon expandable endoprosthesis
5. 18:50 - 19:00
  
  Discussion and conclusion
Tuesday, January 26th: 7:00 - 8:13, Main Arena 1

LINC 2021 CONNECT - China: “Leave nothing behind” – advanced treatment concepts for complex lesions – part I

partially supported by Medtronic

Chairman:

Wei Guo

Moderator:

Dierk Scheinert, Peter Schneider
1. 07:00 - 07:05
  
  Live case transmission from Guangzhou
2. 07:05 - 07:11
  
  What is vessel preparation and why is it important?
3. 07:11 - 07:17
  
  Minimising dissection with the Chocolate balloon
4. 07:17 - 07:23
  
  Directional atherectomy as a vessel preparation tool – evidence and practice
5. 07:23 - 07:53
  
  Live case transmission from Guangzhou
6. 07:53 - 07:59
  
  Efficacy of IN.PACT Admiral DCB – highlights of the IN.PACT Admiral clinical program
7. 07:59 - 08:05
  
  My "leave nothing behind" algorithm
8. 08:05 - 08:13
  
  Panel discussion
Tuesday, January 26th: 8:13 - 9:00, Main Arena 1

LINC 2021 CONNECT - China: “Leave nothing behind” – advanced treatment concepts for complex lesions – part II

Chairman:

Wei Guo

Moderator:

Dierk Scheinert, Thomas Zeller
1. 08:13 - 08:19
  
  DES vs. DCB+BMS are they the same? Insights from the REACT study
2. 08:19 - 08:48
  
  Live case transmission from Leipzig
3. 08:48 - 08:54
  
  The transition from open endarterectomy to interventional treatment of the CFA – how far have we come?
4. 08:54 - 09:00
  
  Interventional treatment of the common femoral artery – update on the PESTO trial
Tuesday, January 26th: 9:05 - 10:20, Main Arena 1

Sirolimus coated balloon: what the FUTURE holds for PAD

supported by Concept Medical

Moderator:

Jos van den Berg

Panel:

Dierk Scheinert, Ulf Teichgräber, Edward Choke, Francesco Liistro
1. 09:05 - 09:13
  
  MagicTouch SCB with Nanolute technology – prospect and appraisal over paclitaxel, insights from the latest pre-clinical data
2. 09:13 - 09:19
  
  First time release of 1-year results of MagicTouch PTA XTOSI trial for SFA and BTK disease
3. 09:19 - 09:25
  
  Updates on FUTURE-SFA and FUTURE-BTK randomised controlled trials
4. 09:25 - 09:33
  
  MagicTouch PTA in BTK and SFA disease – case reviews and discussion
5. 09:33 - 09:51
  
  Live case transmission from Berlin
6. 09:51 - 10:01
  
  Case presentation and introduction of the SIRONA trial
7. 10:01 - 10:09
  
  SirPAD – the largest randomised trial with a Sirolimus coated balloon forperipheral arterial disease treatment
8. 10:09 - 10:15
  
  Debate BTK DueIL trials
9. 10:15 - 10:20
  
  Discussion and conclusion
Tuesday, January 26th: 10:25 - 11:40, Main Arena 1

Acute deep vein thrombosis and post-thrombotic syndrome

Moderator:

Rick de Graaf, Michael Lichtenberg

Panel:

Gerard O'Sullivan, Tim Sebastian, Stefano Barco, Rolf Engelberger, Christian Erbel
1. 10:25 - 10:45
  
  Live case transmission from Zurich
2. 10:45 - 10:51
  
  COVID-19 and venous thromboembolism
3. 10:51 - 10:57
  
  Thrombolysis techniques for iliofemoral DVT
4. 10:57 - 11:03
  
  Mechanical thrombectomy techniques for iliofemoral DVT
5. 11:03 - 11:09
  
  3 year clinical outcomes of dedicated nitinol stents for acute deep vein thrombosis, post-thrombotic syndrome and non-thrombotic iliac vein lesions
6. 11:09 - 11:15
  
  The TOPOS study: 1 year clinical outcomes of a hybrid oblique nitinol stent for PTS patients with common iliac vein compression
7. 11:15 - 11:21
  
  Antithrombotic therapy after venous stents
8. 11:21 - 11:40
  
  Live case transmission from Zurich
Tuesday, January 26th: 11:45 - 12:10, Main Arena 1

Pioneering approaches and new data: focus on venous and AV-shunt treatment

Moderator:

Marianne Brodmann, Michael Lichtenberg

Panel:

Robert Shahverdyan, Tobias Steinke
1. 11:45 - 11:50
  
  FIRST TIME DATA RELEASE: The IN.PACT AV access trial: subset outcomes through 12 month
2. 11:50 - 11:55
  
  The IN.PACT AV access trial – economic outcomes
3. 11:55 - 12:00
  
  VIVO clinical study: Zilver Vena stent – 12 month results
4. 12:00 - 12:05
  
  Data from the ABRE study: clinical patient presentations in iliofemoral venous outflow obstruction – aDVT, PTS, NIVL
5. 12:05 - 12:10
  
  FIRST TIME DATA RELEASE: Retrospective comparison of surgical AV access fistula creation vs. pAVF creation
Tuesday, January 26th: 12:10 - 12:25, Main Arena 1

Pulmonary embolism management: percutaneous mechanical thrombectomy for acute PE

supported by Penumbra

Speaker:

Juan José Ciampi Dopazo
1. Pulmonary embolism management: percutaneous mechanical thrombectomy for acute PE
Tuesday, January 26th: 12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: Leading with evidence: ranger low dose drug coated balloon

supported by Boston Scientific

Moderator:

Koen Deloose

Panel:

Marianne Brodmann, Sabine Steiner, Gergana T. Taneva
1. 12:30 - 12:32
  
  Introduction
2. 12:32 - 12:40
  
  New insights from Ranger DCB in challenging lesions and demographics
3. 12:40 - 12:45
  
  Panel discussion
4. 12:45 - 12:53
  
  New insights from COMPARE 2 year, low dose vs. high dose DCB
5. 12:53 - 12:58
  
  Panel discussion
6. 12:58 - 13:06
  
  Optimizing DCB performance with Jetstream atherectomy
7. 13:06 - 13:11
  
  Panel discussion
8. 13:11 - 13:15
  
  Q&A, discussion, and conclusion
Tuesday, January 26th: 13:20 - 15:00, Main Arena 1

Endovascular procedures for the deep venous system

Moderator:

Houman Jalaie, Gerard O'Sullivan

Panel:

Tobias Hirsch, Raghu Kolluri, Olivier Hartung
1. 13:20 - 13:34
  
  Live case transmission from Zurich
2. 13:34 - 13:47
  
  Recorded case presentation
3. 13:47 - 13:53
  
  IVC obstruction and heart failure with preserved ejection fraction
4. 13:53 - 13:59
  
  IVUS for guiding venous procedures: fancy tool or relevant for clinical outcomes?
5. 13:59 - 14:05
  
  Can advanced venographic techniques substitute IVUS?
6. 14:05 - 14:11
  
  Iliocaval skip stenting technique for chronic venous obstruction
7. 14:11 - 14:17
  
  Recent data on approved venous stents
8. 14:17 - 14:29
  
  Recorded case presentation
9. 14:29 - 14:45
  
  Live case transmission from Zurich
10. 14:45 - 15:00
  
  Q&A, discussion, and conclusion
Tuesday, January 26th: 15:05 - 16:35, Main Arena 1

SYMPOSIUM: The reality of PAD and calcium: treatment strategies for improved outcomes

supported by Medtronic

Moderator:

Dierk Scheinert

Panel:

Thomas Zeller, Giovanni Torsello, Ravish Sachar, Ralf Langhoff
1. 15:05 - 16:05
  
  Live case transmission from Leipzig
2. 16:05 - 16:09
  
  Redefining the management of PAD: a critical look at calcium
3. 16:09 - 16:13
  
  Clinical evidence for vessel preparation followed by DCB in the most challenging lesions
4. 16:13 - 16:17
  
  Panel discussion
5. 16:17 - 16:21
  
  DCB after vessel prep: what is the clinical evidence for long-term effectiveness of DCB to reduce reinterventions?
6. 16:21 - 16:33
  
  Additional strategies, tools and techniques for peripheral vascular therapies: a pre-recorded case
7. 16:33 - 16:35
  
  Closing remarks
Tuesday, January 26th: 16:40 - 17:55, Main Arena 1

SYMPOSIUM: Overcoming challenges in treating iliofemoral deep vein thrombosis

supported by BD

Moderator:

Michael Lichtenberg

Panel:

Bruno Freitas, Gerard O'Sullivan, Houman Jalaie
1. 16:40 - 16:48
  
  Building a venous practice with a multidisciplinary team
2. Recorded case with Aspirex™S in iliofemoral deep vein thrombosis: tips and tricks
3. 17:12 - 17:17
  
  24 month results of the Venovo™ venous stent system VERNACULAR trial
4. 17:17 - 17:35
  
  Recorded case: recanalization of chronic iliofemoral venous occlusion in a patient with PAD
5. 17:35 - 17:55
  
  Panel discussion
Tuesday, January 26th: 18:00 - 19:10, Main Arena 1

SYMPOSIUM: Real-world experience to address aortic challenges: expert panel case discussion on treatment algorithms

supported by Gore & Associates

Moderator:

Marc van Sambeek

Panel:

Theodosios Bisdas, Nimesh Desai, Mauro Gargiulo
1. 18:00 - 18:01
  
  Introduction from the moderator
2. 18:01 - 18:20
  
  Live case transmission from Genoa
3. 18:20 - 18:25
  
  Understanding anatomical complexity and strategies to treat it
4. 18:25 - 18:27
  
  Q&A
5. 18:27 - 18:32
  
  Ensuring clinical effectiveness in challenging EVAR
6. 18:32 - 18:34
  
  Q&A
7. 18:34 - 18:39
  
  Discussion
8. 18:39 - 18:49
  
  Recorded TEVAR case
9. 18:49 - 18:51
  
  Q&A
10. 18:51 - 18:56
  
  Aortic remodeling after thoracic endovascular aortic repair of type B aortic dissections
11. 18:56 - 18:58
  
  Q&A
12. 18:58 - 19:03
  
  Early endovascular treatment of type B dissection: facts to consider and technical learnings
13. 19:03 - 19:05
  
  Q&A
14. 19:05 - 19:10
  
  Discussion and conclusion
Wednesday, January 27th: 7:00 - 9:00, Main Arena 1

LINC 2021 CONNECT – joint session with JET

partially supported by BD

Moderator:

Dierk Scheinert, Hiroyoshi Yokoi

Panel:

Kazushi Urasawa, Giancarlo Biamino, Ralf Langhoff
1. 07:00 - 07:35
  
  Live case transmission from Amagasaki
2. 07:35 - 07:40
  
  CTO technique and the step-up PTA approach
3. 07:40 - 07:45
  
  Subintimal recanalization of peripheral occlusive disease with IVUS guided true lumen re-entry
4. 07:45 - 07:50
  
  The challenge of treating multivessel disease to preserve future treatment options: a case example
5. 07:50 - 07:55
  
  Japan update: optimal strategies for vessel preparation and DCB usage
6. 07:55 - 08:00
  
  Update on Paclitaxel safety from the results of Japanese patients analysis
7. 08:00 - 08:05
  
  Treatment strategy for fempop critical limb-threatening ischemia
8. 08:05 - 08:45
  
  Live case transmission from Leipzig
9. 08:45 - 08:50
  
  4F endovascular treatment is as safe and effective as 6F with no need for VCD: full cohort analysis of the BIO4AMB multicenter trial
10. 08:50 - 08:55
  
  IVUS guided atherectomy and DCB of calcified infrapopliteal disease: PRESTIGE trial update
11. 08:55 - 09:00
  
  Rotational atherectomy in common femoral artery – endovascular treatment in a difficult-to-treat 'surgical' territory
Wednesday, January 27th: 9:05 - 10:20, Main Arena 1

Redefining vascular treatment strategy for AVF and AVG: a deep dive into Sirolimus coated balloon

supported by Concept Medical

Chairman:

Konstantinos Katsanos

Moderator:

Tjun Tang

Panel:

Ounali Jaffer, Tze Tec Chong
1. 09:05 - 09:17
  
  Treatment of AVF Stenosis with DCBs: advantages of Sirolimus over Paclitaxel
2. 09:17 - 09:29
  
  MagicTouch use at the graft-vein junction in thrombosed AVGs – 1 year outcome data
3. 09:29 - 09:35
  
  MATILDA trial 1 year outcomes
4. 09:35 - 09:45
  
  AVF case transmission from Singapore General Hospital
5. 09:45 - 09:55
  
  AVG case transmission from Singapore General Hospital
6. 09:55 - 10:00
  
  Case discussion
7. 10:00 - 10:20
  
  Discussion and conclusion
Wednesday, January 27th: 10:25 - 11:25, Main Arena 1

Innovative concepts in carotid revascularization

Moderator:

Alberto Cremonesi, Marc van Sambeek

Panel:

E. Sebastian Debus, Piero Montorsi, Horst Sievert
1. 10:25 - 10:30
  
  12 month results from a prospective real-world multicenter clinical practice of CAS using the CGuard Embolic Prevention system: the IRONGUARD 2 study
2. 10:30 - 10:55
  
  Live case transmission from Berlin
3. 10:55 - 11:00
  
  Interim 30 day safety outcomes in symptomatic and asymptomatic patients treated with the Roadsaver dual-layer micromesh carotid artery stent: evidence from a large multicentre European ROADSAVER study
4. 11:00 - 11:05
  
  The safety and effectiveness of carotid revascularization with the Acculink stent and the CGuard stent. Independent randomized study
5. 11:05 - 11:10
  
  Proximal protection for carotid artery stenting: a preferred solution for all-comers
6. 11:10 - 11:15
  
  Carotid artery revascularization: a systematic review and meta-analysis comparing clinical outcomes of second vs. first generations stents and CEA
7. 11:15 - 11:20
  
  Proximal vs. distal protection for carotid artery stenting: a review of the data
8. 11:20 - 11:25
  
  State of the art medical management of carotid artery disease in the post COMPASS and VOYAGER study era
Wednesday, January 27th: 11:30 - 12:15, Main Arena 1

SYMPOSIUM: Roadsaver – the power of facts. Dual layer CAS and the growing body of new clinical evidence

supported by Terumo

Moderator:

Piero Montorsi

Panel:

Andrea Kahlberg, Piotr Odrowaz-Pieniazek, Stefan Müller-Hülsbeck
1. 11:30 - 11:33
  
  Introduction
2. 11:33 - 11:43
  
  The vascular surgeon’s perspective: Italian comparative experience of Roadsaver vs. other stents
3. 11:43 - 11:45
  
  Discussion
4. 11:45 - 11:55
  
  Carotid artery stenting with 300 Roadsaver stent implantations. Early and 4 year results
5. 11:55 - 11:57
  
  Discussion
6. 11:57 - 12:07
  
  Roadsaver carotid artery stent for tandem lesions in acute ischemic stroke – the Flensburg experience
7. 12:07 - 12:15
  
  Q&A, discussion, and closure
Wednesday, January 27th: 12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: Sustained limus release will make a difference to your patients

supported by Medalliance

Moderator:

Michael Lichtenberg, Ehrin Armstrong

Panel:

Tjun Tang, Marianne Brodmann
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:43
  
  STEP Up with SELUTION SLR
3. 12:43 - 12:48
  
  Panel discussion
4. 12:48 - 12:56
  
  Importance of "No" Slow Flow Phenomena
5. 12:56 - 13:01
  
  Panel discussion
6. 13:01 - 13:09
  
  Why to choose Sirolimus for my CLI patients?
7. 13:09 - 13:15
  
  Panel discussion
Wednesday, January 27th: 13:30 - 13:45, Main Arena 1

Peripheral clot management – a paradigm shift in arterial clot removal: surgery to endovascular

supported by Penumbra

Speaker:

Gianmarco de Donato
1. Peripheral clot management – a paradigm shift in arterial clot removal: surgery to endovascular
Wednesday, January 27th: 13:55 - 15:10, Main Arena 1

SYMPOSIUM: Spotlight on challenging lower limb cases: tips and tricks for success

supported by BD

Moderator:

Dierk Scheinert

Panel:

Bruno Freitas, Luis Palena, Marc Sirvent
1. 13:55 - 14:03
  
  No increase in all-cause mortality with paclitaxel devices used in lower limb arterial interventions - an interim analysis of SWEDEPAD RCT data
2. 14:03 - 14:18
  
  Recorded case presentation: the importance of vessel prep before DCB to fight against CLI recurrence
3. 14:18 - 14:33
  
  Recorded case: Chronic in-stent re-occlusion left SFA
4. 14:33 - 14:53
  
  Recorded case: Rotarex™S: Rotational atherothrombectomy catheter for an extreme rescue of a previous iliofempop, endovascular treatment for CTLI
5. 14:53 - 15:10
  
  Q&A, discussion, and conclusion
Wednesday, January 27th: 15:15 - 16:30, Main Arena 1

SYMPOSIUM: How predictability and evidence lead to proven patient outcomes

supported by Cook Medical

Moderator:

Michael Dake

Panel:

Thomas Zeller, Carlos Mena-Hurtado, Aloke Finn, Michel Bosiers
1. 15:15 - 15:25
  
  When the benefit of paclitaxel outweigh the risk
2. 15:25 - 15:35
  
  Prediction model for freedom from TLR from a multi-study analysis of long-term results with the Zilver PTX stent
3. 15:35 - 15:45
  
  How the prediction model impact my daily clinical practice
4. 15:45 - 16:15
  
  Live case transmission from Leipzig
5. 16:15 - 16:20
  
  Pre-clinical impact of Eluvia
6. 16:20 - 16:25
  
  Clinical impact of Eluvia
7. 16:25 - 16:30
  
  Q&A, discussion, and conclusion
Wednesday, January 27th: 16:45 - 18:45, Main Arena 1

CONNECT VIVA/LINC – Calcification: the last frontier in vascular therapy

Moderator:

Sean Lyden, Maureen Kohi

Panel:

Raghu Kolluri, Ehrin Armstrong
1. 16:45 - 16:50
  
  Why does it form, what is the pathophysiology and is there a medical treatment on the horizon?
2. 16:50 - 16:55
  
  Calcium grading systems, which one is most accurate?
3. 16:55 - 17:00
  
  What are the best tools to prepare the calcified artery? Atherectomy, serration angioplasty, scoring, lithotripsy
4. 17:00 - 17:15
  
  Panel discussion
5. 17:15 - 17:30
  
  Recorded case from Leipzig: 'Crack & Pave'-technique for extreme calcification
6. ADVICE ABOUT MANAGING CALCIFICATION IN DIFFERENT VASCULAR BEDS: VESSEL PREP, SCAFFOLDS, DRUG DELIVERY, AND OTHER ISSUES OF PROVIDING DEFINITIVE THERAPY IN THIS CHALLENGING SITUATION
7. 17:30 - 17:35
  
  Carotid
8. 17:35 - 17:40
  
  Aortoiliac
9. 17:40 - 17:45
  
  SFA-pop
10. 17:45 - 17:50
  
  Tibial and BTA
11. 17:50 - 18:05
  
  Panel discussion
12. 18:05 - 18:45
  
  Live case transmission from Kingsport
Wednesday, January 27th: 19:00 - 20:20, Main Arena 1

VIVA/LINC – Joint session on the current status and future of drug-eluting therapies

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Andrew Holden, Marianne Brodmann, Robert Lookstein
1. 19:00 - 19:03
  
  Introduction by the moderators
2. 19:03 - 19:08
  
  Insights on paclitaxel safety from the femoral-popliteal RCTs
3. 19:08 - 19:13
  
  Insights on paclitaxel safety from femoral-popliteal real-world data
4. 19:13 - 19:21
  
  New insights from the interim safety analysis of the SWEDEPAD study
5. 19:21 - 19:26
  
  How does the Voyager data help us understand the risks of paclitaxel?
6. 19:26 - 19:31
  
  Paclitaxel safety in patients with CLTI
7. 19:31 - 19:36
  
  Newly FDA-approved paclitaxel devices for lower extremity and dialysis and the regulatory implications
8. 19:36 - 19:41
  
  New data on paclitaxel in the next couple of years; what should we expect?
9. 19:41 - 19:49
  
  Panel discussion
10. 19:49 - 19:54
  
  Paclitaxel vs. limus agents. Mechanism of action, what are the challenges to move beyond paclitaxel?
11. 19:54 - 19:59
  
  Previous experience with limus compounds in the non-coronary arteries; lessons learned
12. 19:59 - 20:04
  
  New limus delivering devices for above and below knee occlusive disease; when to expect results?
13. 20:04 - 20:14
  
  Blue horizon keynote speech: Potential for drug delivery in the treatment of lower extremity occlusive disease: what will the practice look like in 5 years?
14. 20:14 - 20:20
  
  Panel discussion
Thursday, January 28th: 7:00 - 9:00, Main Arena 1

Challenges in EVAR: focus on aortic dissections and innovations for aortic arch treatment

partially supported by Gore & Associates

Moderator:

Tilo Kölbel, Andrew Holden

Panel:

Vicente Riambau, Wei Guo, Vikram Puttaswamy
1. 07:00 - 07:25
  
  Live case transmission from Leipzig
2. 07:25 - 07:30
  
  Type A aortic dissection – current knowledge gaps
3. 07:30 - 07:35
  
  Open and endovascular surgery after frozen elephant trunk for extensive aortic aneurysms
4. 07:35 - 07:40
  
  WeFlow-Arch™: a new modular double inner branch stent graft for endovascular repair of aortic arch pathology
5. 07:40 - 07:45
  
  Off-the-shelf treatment of aortic arch pathologies with Nexus
6. 07:45 - 07:50
  
  Optimizing TEVAR outcomes in acute and subacute type B aortic dissections, what is the right amount of radial force?
7. 07:50 - 07:55
  
  Tailoring the treatment of fragile aorta with the Valiant Navion covered seal device: my clinical experience in TBAD
8. 07:55 - 08:00
  
  Conformability and dissection, is it important?
9. 08:00 - 08:05
  
  Identifying at risk patients: who could benefit from TEVAR in uncomplicated type B dissections
10. 08:05 - 08:10
  
  Short-term results of TEVAR in complicated vs. uncomplicated acute type B aortic dissection: a report from the Gore Global Registry for Endovascular Aortic Treatment (GREAT)
11. 08:10 - 08:15
  
  Meeting an unmet need: the DISSECT-N trial
12. 08:15 - 08:20
  
  Treatment approaches for the distal landing zone for type B dissection
13. 08:20 - 08:25
  
  Multicentre data on the usage of large covered stents in aortic blisters/PAU instead of an EVAR device
14. 08:25 - 08:50
  
  Live case transmission from Universitätsklinik für Herzchirurgie Leipzig
15. 08:50 - 09:00
  
  Q&A, discussion, and conclusion
Thursday, January 28th: 9:15 - 10:15, Main Arena 1

SYMPOSIUM: EVAR imaging innovations for a safer treatment

supported by Siemens Healthineers

Moderator:

Eric Verhoeven

Panel:

Hayato Morimura, Michael Moche, Maani Hakimi
1. 09:15 - 09:20
  
  Introduction
2. 09:20 - 09:25
  
  Artificial intelligence algorithm for an automated assessment of the thoracic aorta
3. 09:25 - 09:30
  
  Coil embolization of internal iliac arteries before EVAR: experience with fusion imaging
4. 09:30 - 10:00
  
  Live case transmission from Münster
5. 10:00 - 10:05
  
  Preconditioning before EVAR with multimodality imaging for embolisation of aortic side branches
6. 10:05 - 10:10
  
  Ultra low dose EVAR: first results
7. 10:10 - 10:15
  
  Q&A, discussion, and conclusion
Thursday, January 28th: 10:45 - 12:15, Main Arena 1

Advanced concepts for Thoracic Endovascular Aortic Repair (TEVAR)

Moderator:

Marc van Sambeek, Jean-Pierre Becquemin

Panel:

Martin Malina, Martin Austermann, Dittmar Böckler
1. 10:45 - 10:51
  
  Fiber Optic RealShape (FORS) technology: 3D device guidance in practice
2. 10:51 - 10:57
  
  Clinical relevance of dynamic 4D analysis in the thoracic aorta throughout the cardiac cycle
3. 10:57 - 11:03
  
  Addressing unmet clinical needs with a new generation TEVAR device: practical application of the Valiant Navion
4. 11:03 - 11:09
  
  Valiant Navion: what have we learned about this next Generation TEVAR device: 1 year results from the global clinical trial and new mormphetry insights
5. 11:09 - 11:15
  
  A multi-center, independent, real-world study of the Valiant Navion stent graft
6. 11:15 - 11:45
  
  Live case transmission from Paris
7. 11:45 - 11:51
  
  Durable thoracic outcome throughout 5 year clinical follow up
8. 11:51 - 11:57
  
  3 years of experience in more than 100 patients using TAG conformable with active control: what did we learn?
9. 11:57 - 12:03
  
  Endoanchors in TEVAR: how this application can add confidence to your practice
10. 12:03 - 12:09
  
  How does the Advanta V12 make a difference and leads the way
11. 12:09 - 12:15
  
  Q&A, discussion, and conclusion
Thursday, January 28th: 12:20 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: From benchtop to bedside: elevating EVAR and TEVAR through Medtronic technologies

supported by Medtronic

Moderator:

Vicente Riambau, Jean-Paul de Vries

Panel:

Hence Verhagen, Vikram Puttaswamy, Yamume Tshomba
1. 12:20 - 12:30
  
  Why sac regression matters: how our experience with Endurant informs our practice
2. 12:30 - 12:40
  
  How to approach challenging necks with off-the-shelf solutions
3. 12:40 - 12:50
  
  New features associated with Valiant Navion covered seal that tailor fragile aorta treatment
4. 12:50 - 13:15
  
  Discussion, Q&A
Thursday, January 28th: 13:20 - 14:50, Main Arena 1

EVAR for Thoracoabdominal Aortic Aneurysms (TAAA)

Moderator:

Giovanni Torsello, Stéphan Haulon, Tilo Kölbel

Panel:

Eric Verhoeven, Mauro Gargiulo, Piotr Kasprzak
1. 13:20 - 13:28
  
  Knowledge driven approach to manage TAAAs
2. 13:28 - 13:48
  
  Live case transmission from Hamburg
3. 13:48 - 13:56
  
  Overcoming challenging TAAAs anatomies with CMD endografts
4. 13:56 - 14:01
  
  How to handle the specific anatomical issues in post-dissection-TAAA
5. 14:01 - 14:06
  
  Advantages of balloon expandable covered bridging stents in F/B/EVAR procedures: which one is best and why
6. 14:06 - 14:11
  
  The E-nside inner branches technology – an approach to make TAAA-EVAR more efficient?
7. 14:11 - 14:16
  
  Multicentre (London/Nuremberg) clinical experience in BEVAR procedures – what do new devices offer me as a surgeon
8. 14:16 - 14:25
  
  Live case transmission from Hamburg
9. 14:25 - 14:30
  
  Insight in the German BEVAR approval study to get bridging stents approved for the indication
10. 14:30 - 14:35
  
  New Advanta FEVAR and BEVAR long-term data
11. 14:35 - 14:40
  
  Respiratory-induced dynamics of the BeGraft stent in FEVAR
12. 14:40 - 14:45
  
  Spinal cord protection by selective segmental artery coil embolization – update on the PAPA-ARTIS trial
13. 14:45 - 14:50
  
  Open TAAA repair in patients with connective tissue disorders
Thursday, January 28th: 14:55 - 16:10, Main Arena 1

SYMPOSIUM: Cook thoracic solution – expand your treatment options

supported by Cook Medical

Moderator:

Eric Verhoeven

Panel:

Nikolaos Tsilimparis, Germano Melissano, Nilo Mosquera
1. 14:55 - 15:00
  
  Introduction
2. 15:00 - 15:08
  
  Zenith Alpha TAA: why Alpha TAA is my preferred thoracic endograft
3. 15:08 - 15:38
  
  Live case transmission from Münster – part I
4. 15:38 - 15:46
  
  Zenith Alpha TAA: clinical outcomes after 5 years of follow up
5. 15:46 - 15:54
  
  For emergent and standard cases: Zenith t-Branch does the job
6. 15:54 - 16:00
  
  Live case transmission from Münster – part II
7. 16:00 - 16:10
  
  Q&A
Thursday, January 28th: 16:15 - 18:00, Main Arena 1

Current concepts, innovations, and open questions in EVAR of complex infrarenal aortoiliac aneurysms

Moderator:

Giovanni Torsello, Frank Veith

Panel:

Armando Lobato, Eric Verhoeven, Konstantinos Donas
1. 16:15 - 16:40
  
  Live case transmission from Paris
2. 16:40 - 16:45
  
  Best practices and technical learning on the on-label treatment of challenging necks: The EXCeL registry
3. 16:45 - 16:50
  
  Contemporary options for treating juxtarenal aneurysm when infrarenal sealing is not enough
4. 16:50 - 16:55
  
  EndoAnchors can facilitate and maintain successful standard EVAR for AAAs with challenging proximal necks
5. 16:55 - 17:00
  
  FEVAR technique – a case presentation
6. 17:00 - 17:05
  
  4xFEVAR: is it always needed to stent the celiac artery?
7. 17:05 - 17:10
  
  Data on the 3 year clinical results of BeGraft in FEVAR
8. 17:10 - 17:15
  
  Insight in the German FEVAR approval study to get bridging stents approved for the indication
9. 17:15 - 17:20
  
  WeFlow-JAAA™: a new uncustomized device for juxtarenal AAA
10. 17:20 - 17:25
  
  Type II endoleak and aortic aneurysm sac shrinkage after pre-emptive embolization of aneurysm sac side branches
11. 17:25 - 17:40
  
  Live case transmission from Leipzig
12. 17:40 - 17:45
  
  How stent graft design influences overall AAA sac dynamics and overall therapy success
13. 17:45 - 17:50
  
  EVAR long term perspectives: facts and figures from the GREAT registry experience at 5 years
14. 17:50 - 17:55
  
  How and why do the Endurant endograft results for EVAR in France differ from the global results: what are the implications
15. 17:55 - 18:00
  
  How sac regression at 1 year affects all-cause mortality through 5 year: key insights from the ENGAGE registry
Thursday, January 28th: 18:10 - 18:55, Main Arena 1

How should you approach patients with a vasculogenic erectile dysfunction?

supported by Concept Medical

Moderator:

Roxana Mehran, Giuseppe Massimo Sangiorgi

Panel:

Theodosios Bisdas
1. 18:10 - 18:15
  
  Vasculogenic erectile dysfunction: we don’t ask, they don’t talk
2. 18:15 - 18:20
  
  What current European guidelines suggest for the treatment of erectile dysfunction
3. 18:20 - 18:26
  
  How cardiologists should approach the patients with erectile dysfunction
4. 18:26 - 18:32
  
  Treatment of erectile dysfunction: from pills to balloons and stents
5. 18:32 - 18:40
  
  Clinical cases
6. 18:40 - 18:47
  
  Clinical cases
7. 18:47 - 18:55
  
  Panel discussion and conclusion
Thursday, January 28th: 19:00 - 20:30, Main Arena 1

SYMPOSIUM: Complex femoropopliteal lesions and new treatment options

supported by BD

Moderator:

Dierk Scheinert

Panel:

Miguel Montero-Baker, George Adams, Andrej Schmidt
1. 19:00 - 19:30
  
  Live case transmission from Leipzig
2. 19:30 - 19:50
  
  Prevalence of mixed morphology pathology within peripheral arterial disease
3. 19:50 - 20:10
  
  Overview of the Rotarex™ rotational atherectomy system
4. 20:10 - 20:30
  
  Case review from US center
Friday, January 29th: 7:00 - 9:00, Main Arena 1

Novel techniques for treatment of complex BTK disease in CLI

Moderator:

Jos van den Berg, Steven Kum

Panel:

Roberto Ferraresi, Andrew Holden, Luis Palena
1. 07:00 - 07:30
  
  Live case transmission from Beijing
2. 07:30 - 07:35
  
  Tips and tricks for optimal angiographic imaging of BTK and foot arteries
3. 07:35 - 07:40
  
  Indirect vs. direct revascularization for CLI treatment: best practice in 2021
4. 07:40 - 07:45
  
  Balloon angioplasty of infrapopliteal arteries: a proposed algorithm for optimal endovascular treatment
5. 07:45 - 07:50
  
  Is bigger better in BTK arteries? The role luminal gain and how to avchieve it?
6. 07:50 - 07:55
  
  The PRELUDE-BTK study: novel serration angioplasty balloon for below-the-knee arteries
7. 07:55 - 08:25
  
  Live case transmission from Abano Terme
8. 08:25 - 08:30
  
  Dissection repair in below-the-knee: evidence review and learnings from the TOBA II BTK trial
9. 08:30 - 08:35
  
  Where do we stand with DCB therapy in BTK arteries?
10. 08:35 - 08:40
  
  The drug-coated temporary spur stent system: innovation in drug delivery for treating CLI
11. 08:40 - 08:45
  
  XTOSI 12 month results: Xtreme Touch-Neo (MagicTouch PTA) Sirolimus coated balloon for peripheral arterial disease
12. 08:45 - 08:50
  
  BTK interventions in 2025: what is going to help to make BTK procedures more effective?
13. 08:50 - 09:00
  
  Discussion and conclusion
Friday, January 29th: 9:15 - 10:30, Main Arena 1

SYMPOSIUM: Guidewire strategy for difficult BTK recanalisation

supported by Asahi Intecc

Moderator:

Roberto Ferraresi

Panel:

Koen Deloose, Ralf Langhoff, Daniel van den Heuvel
1. 09:15 - 09:20
  
  Introduction
2. 09:20 - 09:30
  
  Selecting the right wire for the right case
3. 09:30 - 09:40
  
  Crossing tough CTOs
4. 09:40 - 09:50
  
  My experience with Gladius MG PV
5. 09:50 - 10:20
  
  Live case transmission from Leipzig
6. 10:20 - 10:30
  
  Q&A, discussion, and conclusion
Friday, January 29th: 10:45 - 12:15, Main Arena 1

Pioneering techniques and new data for CLI treatment

Moderator:

Roberto Ferraresi, Marianne Brodmann

Panel:

Steven Kum, Jean-Paul de Vries, Giacomo Clerici
1. 10:45 - 10:50
  
  CO2 angiography guided interventions in critical limb ischemia: how to do it?
2. 10:50 - 11:20
  
  Live case transmission from Abano Terme
3. 11:20 - 11:25
  
  Medial artery calcification (MAC) and it's relevance for wound healing and limb salvage
4. 11:25 - 11:30
  
  Imaging techniques to determine tissue perfusion in critical limb ischemia
5. 11:30 - 11:35
  
  Applicability of hyperspectral imaging to determine tissue perfusion in peripheral arterial disease
6. 11:35 - 11:40
  
  The concept of deep venous arterialization (DVA) – how do DVA results compare with standard revascularization techniques?
7. 11:40 - 11:55
  
  Recorded case: deep venous arterialization
8. 11:55 - 12:00
  
  Comparison of outcomes from the latest LimFlow data from the PROMISE I (12 month data) and ALPS (24 month data)
9. 12:00 - 12:05
  
  Post DVA patient management and wound care strategy
10. 12:05 - 12:10
  
  DVA tips/tricks and lessons learned
11. 12:10 - 12:15
  
  Discussion and conclusion
Friday, January 29th: 12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: Highest quality of care in complex EVAR procedure with advanced imaging techniques from planning to follow up

supported by Philips

Moderator:

Marc Schermerhorn

Panel:

Kak Khee Yeung, Henrik Sillesen, Jörg Teßarek
1. 12:30 - 12:44
  
  Improving EVAR outcome from planning to live using new generation of Azurion platform
2. 12:44 - 12:55
  
  Improving AAA measurement accuracy using innovative ultrasound 3D volume model automation and xMATRIX
3. 12:55 - 13:05
  
  New generation mobile C-Arms. Do they meet the needs for safe and reliable EVAR
4. 13:05 - 13:15
  
  Q&A, discussion, and closure
Friday, January 29th: 13:20 - 14:45, Main Arena 1

Endovascular solutions and innovative approaches for challenging aortic pathologies

Moderator:

Martin Austermann, Frank Veith, Tilo Kölbel

Panel:

Daniela Branzan, Jean-Pierre Becquemin, Giovanni Pratesi, Roger Greenhalgh
1. FOCUS ON AORTOILIAC ANEURYSMS
2. 13:20 - 13:25
  
  Clinical results and technical learnings in challenging iliac aneurysmatic disease
3. 13:25 - 13:30
  
  Aortic endografting with iliac side branch devices – lessons learned from the largest international registry (pELVIS)
4. 13:30 - 13:35
  
  IceBERG registry: improving patient health care with hypogastric preservation
5. 13:35 - 13:55
  
  Live case transmission from Hamburg
6. FOCUS ON RUPTURED AND MYCOTIC ANEURYSM
7. 13:55 - 14:00
  
  The importance of detection of sac growth after endovascular aortic aneurysm repair
8. 14:00 - 14:05
  
  Evolution of EVAR as the treatment of choice for ruptured AAAs
9. 14:05 - 14:10
  
  Effect of centralization on ruptured abdominal aortic aneurysm outcomes
10. 14:10 - 14:15
  
  Best practice for EVAR of ruptured aortic aneurysms
11. 14:15 - 14:20
  
  Ruptured TAAA: how I do it
12. 14:20 - 14:25
  
  Advanced concepts for EVAR of acute thoracoabdominal aneurysms
13. 14:25 - 14:30
  
  Mycotic aneurysms revisited: 20 year experience with non-radical treatment
14. 14:30 - 14:35
  
  Minimizing dose in complex EVAR procedures
15. 14:35 - 14:45
  
  Live case transmission from Hamburg
Friday, January 29th: 14:50 - 15:35, Main Arena 1

DEEP DIVE SESSION: Management of AV-access obstructions

Moderator:

Robert Lookstein, Jos van den Berg

Panel:

Jeffrey Hull, Robert Jones, Henrik Sillesen
1. 14:50 - 14:55
  
  Restoring arteriovenous access: pilot study using a scoring balloon in 50 patients
2. 14:55 - 15:00
  
  Ultrasound guided PTA of AV fistula – improve care for your patients and increase capacity of your angiosuite
3. 15:00 - 15:05
  
  The IN.PACT AV access trial – the data so far
4. 15:05 - 15:10
  
  Safety and efficacy of drug eluting balloon angioplasty of dialysis fistula: 12 month outcomes from a randomized clinical trial with Passeo-18 Lux
5. 15:10 - 15:15
  
  1 year results from the MAgicTouch intervention leap for dialysis access – the MATILDA trial
6. 15:15 - 15:20
  
  The role of balloon angioplasty and stent-grafts in my treatment algorithm for hemodialysis access salvage
7. 15:20 - 15:25
  
  Treating AVF lesions in the cephalic arch: cases and context
8. 15:25 - 15:30
  
  Management of cephalic arch stenosis: have stent-grafts become the gold standard?
9. 15:30 - 15:35
  
  Maturation for hemodialysis in the Ellipsys registry
Friday, January 29th: 15:40 - 16:55, Main Arena 1

SYMPOSIUM: Revolutionary arteriovenous fistula creation: an endovascular approach

supported by BD

Moderator:

Matteo Tozzi

Panel:

Nicholas Inston, Robert Jones, Ounali Jaffer, Panagiotis Kitrou
1. 15:40 - 15:45
  
  Covid a catalyst for change: expanding you dialysis access options
2. 15:45 - 15:55
  
  Proven clinical results of AVF creation with WavelinQ™ EndoAVF system
3. 15:55 - 16:02
  
  First time announcement of clinical study protocols: 1. The WavelinQ™ EndoAVF system arterio-venous endovascular fistula: a global, post-market investigation (WAVE-Global) 2. Post-market surveillance study of the WavelinQ™ EndoAVF system (CONNECT-AV)
4. 16:02 - 16:17
  
  Recorded case: WavelinQ™ EndoAVF creation with a radial-radial wrist access
5. 16:17 - 16:25
  
  Panel discussion
6. 16:25 - 16:40
  
  Recorded case: WavelinQ™ EndoAVF creation with a brachial-basilic access
7. 16:40 - 16:55
  
  Panel discussion
Friday, January 29th: 17:00 - 18:15, Main Arena 1

Innovative concepts for peripheral interventions

Moderator:

Theodosios Bisdas, Marianne Brodmann

Panel:

Giancarlo Biamino, Ralf Langhoff, Spiridon Botsios
1. 17:00 - 17:05
  
  Enabling procedural support and skill advancement during the Covid19 pandemic: remote real time training and proctoring on a low latency streaming platform
2. FOCUS ON CAROTID DISEASE
3. 17:05 - 17:10
  
  Effect of drug therapy on the incidence of embolic complications of reconstructive interventions on the carotid arteries
4. 17:10 - 17:15
  
  Assessment of carotid plaque morphology using photoacoustic imaging
5. 17:15 - 17:35
  
  Recorded case from Leipzig: CGuard-stent in a CCA-stenosis
6. 17:35 - 17:40
  
  Improving your safety profile through proximal protection: experiences from a high volume carotid artery stenting center
7. 17:40 - 17:45
  
  CGuard™ MicroNet covered stent: accumulative clinical evidences
8. FOCUS ON COMPLEX FEMORO-POPLITEAL LESIONS
9. 17:45 - 17:50
  
  The role of IVUS in contemporary endovascular treatment
10. 17:50 - 18:10
  
  Live case transmission from Münster
11. 18:10 - 18:15
  
  Discussion and conclusion

Notice

LINC 2021 programme

LINC 2021 programme

Main Arena 1

Advanced concepts for complex aortoiliac obstructions

Live case transmission from Leipzig

The CERAB technique – procedural tips and clinical outcome

Clinical experience between kissing stents and CERAB

Outcomes of self expanding PTFE covered stent vs. bare metal stent for chronic iliac artery occlusion

FLEX study: 3 year follow-up of patients with iliac occlusive disease treated with the Viabahn balloon-expandable endoprosthesis

Live case transmission from Münster

Ambulatory treatment and the advantages of trans-radial access

Covered stents in emergencies – why should we all have enough covered stents on the shelf?

My algorithm for aortoiliac occlusive disease treatment: from easy lesions to juxtarenal total aortoiliac occlusions: which technique for which lesion

Q&A, discussion, and conclusion

SYMPOSIUM: Stepping towards optimized lower limb treatment – meet the experts

Recorded case presentation: Supera-implantation for a severely calcified popliteal artery-CTO

Panel discussion: step by step approach on treating patients with complex SFA

Live case transmission from Leipzig: BTK-Intervention

Panel discussion: tips and tricks for sustainable BTK results

Panel discussion: how you close your procedures in the context of Covid?

Late breaking trial session: pioneering approaches and new data for BTK interventions

IN.PACT BTK randomized study: 9 month primary outcomes

Chinese experience of DCB in BTK: 12 month results of the AcoArt II study

Latest data of DCB in BTK: 12 month results of the AcoArt BTK Italy study

Luminor in BTK: MERLION trial 12 month outcomes presented for the first time

Temsirolimus adventitial delivery to improve ANGiographic Outcomes below the knee (TANGO)

PRESTIGE-study: 12 month results with the SELUTION sirolimus coated balloon in TASC C and D tibial occlusive disease

A pilot study examining the performance and safety of the temporary spur stent system in infrapopliteal arteries: first-time use with a Limus-coated balloon (DEEPER LIMUS)

DEEPER OUS trial: a multicenter, single arm trial of the novel temporary spur stent system used in conjunction with a commercially available, paclitaxel-coated balloon

12 month data from the LimFlow PROMISE I US early feasibility study

Live case transmission from Leipzig

SYMPOSIUM: A new era for vascular access: evidence-based strategies for optimizing AV fistula creation and maintenance

Introduction

Panel discussion

Endovascular or surgical AV access creation: which option for which patient?

Panel discussion

Challenges in AV access maintenance: treating the cephalic arch

Panel discussion

My AV access maintenance algorithm

Panel discussion and programme conclusions

LUNCH SYMPOSIUM: Is there any DCB covering your needs? Updated efficacy and safety evidence

Introduction

Live case transmission from Sonneberg

First Luminor safety and efficacy outcomes at 3.5 years

Long and complex lesion management, new 2 years data. 1+1=3

BTK experience, Luminor outcomes at 1 year

Q&A, discussion, and closure

LATE BREAKING TRIAL SESSION: New data and innovative concepts for treatment of femoral arteries – part I

FOCUS ON DRUG-ELUTING TECHNOLOGIES

IN.PACT global full clinical cohort: 5 year outcomes

The real-world CONSEQUENT ALL COMERS study

Final long-term mortality results of paclitaxel-coated DCBs from the ILLUMENATE RCTs

5 year outcomes from the IN.PACT global Asian cohort

3 year outcomes of the novel KANSHAS drug-coated balloon in treatment of femoropopliteal occlusive disease: the first-in-human KANSHAS 1 study results

New safety and effectiveness data of Luminor DCB: EffPac trial 3.5 years

Results of the TRANSCEND study – the randomized and controlled noninferiority trial to evaluate safety and clinical efficacy of the SurVeil™ drug-coated balloon compared to IN.PACT® Admiral® drug-coated balloon in the treatment of femoropopliteal artery disease

2 year results from the COMPARE-trial comparing low-dose (Ranger) vs. high-dose (Impact) DCB in femoropopliteal arteries

First peripheral drug-eluting stent clinical results from China: 1 year outcomes of the Zilver PTX China study

MIMICS-3D: 2 year data from the BioMimics 3D Real world registry

The vacuum-assisted thromboaspiration in patients with acute lower limb ischaemia: safety and efficacy results from the INDIAN registry

LATE BREAKING TRIAL SESSION: New data and innovative concepts for treatment of femoral arteries – part II

FOCUS ON NEW DATA FOR COMPLEX LESIONS

IN.PACT global 4 year DCB alone vs. DCB + provisional stenting outcomes

24 month outcomes of the combination of Luminor and iVolution in 24 cm lesions: TINTIN trial

12 month outcomes from the Japanese post-market surveillance study of the Viabahn endoprosthesis as treatment for symptomatic peripheral arterial disease in the superficial femoral arteries

Outcomes in CLI patients treated with DCB: 4 year results from the IN.PACT global study

REALITY study 12 month outcomes: safety and effectiveness of directional atherectomy followed by DCB

Laser atherectomy combined with drug-coated balloon angioplasty is associated with improved 1 year outcomes for the treatment of Tosaka II and III femoropopliteal in-stent restenosis

In-tack restenosis vs. in-stent restenosis

TORUS2 late breaking clinical trial data: preliminary 12 month results from interim analysis of the TORUS stent graft

Fully percutaneous femoropopliteal bypass of complex PAD: population analysis and 24 month results from the DETOUR1 clinical trial

SYMPOSIUM: Image guided therapy for lower limb revascularization: state of the art

Introduction

Utilizing complementary imaging modalities to guide strategy and optimize outcomes

The ABCs of intravascular imaging in contemporary lower limb revascularization

Live case transmission from Arnsberg

An optimized angioplasty paradigm: image guided dissection detection and management with a first of its kind dissection repair device

Recorded case presentation: See clearly treat optimally masterclass

Discussion and conclusion